Table 1

Clinical characteristics of patients undergoing LAGB

Before LAGBAfter LAGBp Value
N (female/male)28 (21/7)
Age (years)38 (19–66)
BMI (kg/m2)43.01±3.7035.7±4.53<0.001
Fasting glucose (mg/dL)103.02±17.8189.47±9.17<0.001
Insulin (U/L)20.85±15.0611.89±7.87<0.001
HOMA5.53±4.542.71±2.05<0.001
AST (U/L)30.59±12.9325.44±7.140.058
ALT (U/L)36.45±27.9023.89±12.30<0.05
GGT (U/L)36.04±24.5725.64±16.41<0.01
AP (U/L)66.86±17.8766.00±11.370.838
CRP (mg/dL)1.01±0.730.63±0.35<0.05
Leucocyte count (g/L)7.32±1.886.48±1.39<0.05
  • ALT, alanine transaminase; AP, alkaline phosphatase; AST, aspartate transaminase; BMI, body mass index; CRP, C reactive protein; GGT, γ-glutamyltransferase; HOMA, homeostasis model assessment; LAGB, laparoscopic adjustable gastric banding.